name,category,termsATPase, Na+/K+ transporting, alpha 3 polypeptide,INTERPRO[450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005228$IPR005775:ATPase, P-type cation exchange, alpha subunit, eukaryotic, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005505$IPR006069:ATPase, P-type cation exchange, alpha subunit, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Na+/K+ transporting, alpha 3 polypeptide,KEGG_PATHWAY[470038844$hsa04260:Cardiac muscle contraction, 470038890$hsa04960:Aldosterone-regulated sodium reabsorption]
ATPase, Na+/K+ transporting, alpha 3 polypeptide,OMIM_DISEASE[520001615$Dystonia-12]
ATPase, Na+/K+ transporting, alpha 3 polypeptide,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Na+/K+ transporting, alpha 3 polypeptide,SP_PIR_KEYWORDS[790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000446$disease mutation, 790000477$dystonia, 790000679$heterodimer, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001108$Parkinsonism, 790001162$phosphoprotein, 790001226$potassium, 790001229$potassium transport, 790001418$Sodium, 790001421$Sodium transport, 790001422$sodium/potassium transport, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
ATPase, Na+/K+ transporting, alpha 3 polypeptide,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850061285$chain:Sodium/potassium-transporting ATPase subunit alpha-3, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850112675$region of interest:Interaction with phosphoinositide-3 kinase, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
LIM domain kinase 2,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001316$IPR001478:PDZ/DHR/GLGF, 450001575$IPR001781:Zinc finger, LIM-type, 450007363$IPR008025:PKC-activated phosphatase-1 inhibitor, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
LIM domain kinase 2,KEGG_PATHWAY[470038851$hsa04360:Axon guidance, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038881$hsa04810:Regulation of actin cytoskeleton]
LIM domain kinase 2,PIR_SUPERFAMILY[630000707$PIRSF000600:LIM protein kinase]
LIM domain kinase 2,SMART[760000114$SM00132:LIM, 760000200$SM00228:PDZ]
LIM domain kinase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000864$LIM domain, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001648$zinc]
LIM domain kinase 2,UP_SEQ_FEATURE[850000242$binding site:ATP, 850028651$chain:LIM domain kinase 2, 850104717$domain:LIM zinc-binding 1, 850104718$domain:LIM zinc-binding 2, 850104918$domain:PDZ, 850105086$domain:Protein kinase, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
RAS protein activator like 3,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
RAS protein activator like 3,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450001635$IPR001849:Pleckstrin homology, 450001714$IPR001936:Ras GTPase-activating protein]
RAS protein activator like 3,SMART[760000205$SM00233:PH, 760000211$SM00239:C2, 760000292$SM00323:RasGAP]
RAS protein activator like 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000640$GTPase activation, 790001162$phosphoprotein, 790001212$polymorphism]
RAS protein activator like 3,UP_SEQ_FEATURE[850056706$chain:RAS protein activator like-3, 850102404$compositionally biased region:Arg-rich, 850102573$compositionally biased region:Poly-Gly, 850102586$compositionally biased region:Pro-rich, 850103199$domain:C2, 850104979$domain:PH, 850105148$domain:Ras-GAP, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
SLAIN motif family, member 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein]
SLAIN motif family, member 2,UP_SEQ_FEATURE[850060946$chain:SLAIN motif-containing protein 2, 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850117294$sequence conflict]
TRAF3 interacting protein 2,INTERPRO[450012192$IPR013568:SEFIR]
TRAF3 interacting protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
TRAF3 interacting protein 2,UP_SEQ_FEATURE[850003830$chain:Adapter protein CIKS, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
WD repeat domain 33,INTERPRO[450001490$IPR001680:WD40 repeat, 450007490$IPR008160:Collagen triple helix repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 33,SMART[760000289$SM00320:WD40]
WD repeat domain 33,SP_PIR_KEYWORDS[790000012$acetylation, 790000345$collagen, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 33,UP_SEQ_FEATURE[850100737$chain:WD repeat-containing protein 33, 850103389$domain:Collagen-like, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117294$sequence conflict, 850117295$sequence variant]
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8,INTERPRO[450004794$IPR005331:Carbohydrate sulfotransferase, 8-13, 450016317$IPR018011:Carbohydrate sulfotransferase-related]
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8,OMIM_DISEASE[520002058$Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity]
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8,SP_PIR_KEYWORDS[790000232$carbohydrate metabolism, 790000356$complete proteome, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8,UP_SEQ_FEATURE[850009417$chain:Carbohydrate sulfotransferase 8, 850105770$glycosylation site:N-linked (GlcNAc...), 850106312$nucleotide phosphate-binding region:PAPS, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
chromosome 17 open reading frame 39,INTERPRO[450016890$IPR018618:Vacuolar import and degradation protein Vid24]
chromosome 17 open reading frame 39,PIR_SUPERFAMILY[630028865$PIRSF037319:vacuole import and degradation protein Vid24]
chromosome 17 open reading frame 39,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 17 open reading frame 39,UP_SEQ_FEATURE[850073369$chain:Uncharacterized protein C17orf39, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict]
chromosome 5 open reading frame 44,INTERPRO[450009439$IPR010378:Protein of unknown function DUF974]
chromosome 5 open reading frame 44,PIR_SUPERFAMILY[630007692$PIRSF008023:uncharacterized conserved protein]
chromosome 5 open reading frame 44,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 5 open reading frame 44,UP_SEQ_FEATURE[850097690$chain:UPF0533 protein C5orf44, 850117294$sequence conflict, 850118574$splice variant]
cytochrome P450, family 2, subfamily F, polypeptide 1,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 2, subfamily F, polypeptide 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 2, subfamily F, polypeptide 1,KEGG_PATHWAY[470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450]
cytochrome P450, family 2, subfamily F, polypeptide 1,PIR_SUPERFAMILY[630000058$PIRSF000045:cytochrome P450 CYP2D6]
cytochrome P450, family 2, subfamily F, polypeptide 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000314$chromoprotein, 790000356$complete proteome, 790000488$electron transfer, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000959$microsome, 790000984$Monooxygenase, 790001092$oxidoreductase, 790001212$polymorphism, 790001556$transmembrane protein]
cytochrome P450, family 2, subfamily F, polypeptide 1,UP_SEQ_FEATURE[850013741$chain:Cytochrome P450 2F1, 850106026$metal ion-binding site:Iron (heme axial ligand), 850117294$sequence conflict, 850117295$sequence variant]
dynactin 1 (p150, glued homolog, Drosophila),BIOCARTA[30000173$h_Lis1Pathway:Lissencephaly gene (LIS1) in neuronal migration and development]
dynactin 1 (p150, glued homolog, Drosophila),INTERPRO[450000819$IPR000938:Cytoskeleton-associated protein, CAP-Gly]
dynactin 1 (p150, glued homolog, Drosophila),KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
dynactin 1 (p150, glued homolog, Drosophila),OMIM_DISEASE[520000291$Amyotrophic lateral sclerosis, susceptibility to, 520003611$Neuropathy, distal hereditary motor, type VIIB, 520003965$Perry syndrome]
dynactin 1 (p150, glued homolog, Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000475$dynein, 790000960$microtubule, 790001015$neurodegeneration, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
dynactin 1 (p150, glued homolog, Drosophila),UP_SEQ_FEATURE[850016476$chain:Dynactin subunit 1, 850102597$compositionally biased region:Ser-rich, 850103282$domain:CAP-Gly, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
ethylmalonic encephalopathy 1,INTERPRO[450001128$IPR001279:Beta-lactamase-like]
ethylmalonic encephalopathy 1,OMIM_DISEASE[520001815$Ethylmalonic encephalopathy]
ethylmalonic encephalopathy 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000743$hydrolase, 790000937$metal-binding, 790000969$mitochondrion, 790001065$nucleus, 790001162$phosphoprotein, 790001550$transit peptide, 790001648$zinc]
ethylmalonic encephalopathy 1,UP_SEQ_FEATURE[850045777$chain:Protein ETHE1, mitochondrial, 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850106258$modified residue, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
glycine receptor, alpha 1,INTERPRO[450005468$IPR006028:Gamma-aminobutyric acid A receptor, 450005469$IPR006029:Neurotransmitter-gated ion-channel transmembrane region, 450005627$IPR006201:Neurotransmitter-gated ion-channel, 450005628$IPR006202:Neurotransmitter-gated ion-channel ligand-binding, 450007462$IPR008127:Glycine receptor alpha, 450007463$IPR008128:Glycine receptor alpha1, 450016308$IPR018000:Neurotransmitter-gated ion-channel, conserved site]
glycine receptor, alpha 1,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
glycine receptor, alpha 1,OMIM_DISEASE[520002425$Hyperekplexia and spastic paraparesis, 520004673$Startle disease, autosomal recessive, 520004674$Startle disease/hyperekplexia, autosomal dominant, 520004699$Stiff person syndrome]
glycine receptor, alpha 1,PIR_SUPERFAMILY[630002560$PIRSF002443:acetylcholine receptor]
glycine receptor, alpha 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000295$chloride, 790000296$chloride channel, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001223$postsynaptic cell membrane, 790001301$receptor, 790001405$signal, 790001475$synapse, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
glycine receptor, alpha 1,UP_SEQ_FEATURE[850021993$chain:Glycine receptor subunit alpha-1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850114708$region of interest:Strychnine-binding, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
granzyme M (lymphocyte met-ase 1),INTERPRO[450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
granzyme M (lymphocyte met-ase 1),PIR_SUPERFAMILY[630001286$PIRSF001135:trypsin]
granzyme M (lymphocyte met-ase 1),SMART[760000013$SM00020:Tryp_SPc]
granzyme M (lymphocyte met-ase 1),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000406$cytolysis, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790001212$polymorphism, 790001252$Protease, 790001363$Secreted, 790001383$Serine protease, 790001386$serine proteinase, 790001405$signal, 790001652$zymogen]
granzyme M (lymphocyte met-ase 1),UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850022382$chain:Granzyme M, 850102883$disulfide bond, 850104964$domain:Peptidase S1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850109636$propeptide:Activation peptide, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
histidyl-tRNA synthetase 2, mitochondrial (putative); D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae),COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
histidyl-tRNA synthetase 2, mitochondrial (putative); D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae),INTERPRO[450002058$IPR002314:Aminoacyl-tRNA synthetase, class II (G, H, P and S), conserved region, 450003274$IPR003732:D-tyrosyl-tRNA(Tyr) deacylase, 450003665$IPR004154:Anticodon-binding, 450004009$IPR004516:Histidyl-tRNA synthetase, class IIa, 450005622$IPR006195:Aminoacyl-tRNA synthetase, class II, conserved region, 450014238$IPR015807:Histidyl-tRNA synthetase, class IIa, subgroup]
histidyl-tRNA synthetase 2, mitochondrial (putative); D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae),KEGG_PATHWAY[470038807$hsa00970:Aminoacyl-tRNA biosynthesis]
histidyl-tRNA synthetase 2, mitochondrial (putative); D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae),PIR_SUPERFAMILY[630001717$PIRSF001549:His-tRNA_synth, 630001718$PIRSF001549:histidyl-tRNA synthetase]
histidyl-tRNA synthetase 2, mitochondrial (putative); D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000066$Aminoacyl-tRNA synthetase, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000859$ligase, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001255$protein biosynthesis, 790001550$transit peptide]
histidyl-tRNA synthetase 2, mitochondrial (putative); D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae),UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850014256$chain:D-tyrosyl-tRNA(Tyr) deacylase 1, 850042305$chain:Probable histidyl-tRNA synthetase, mitochondrial, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand, 850118617$transit peptide:Mitochondrion]
lipase, hepatic,INTERPRO[450000631$IPR000734:Lipase, 450000897$IPR001024:Lipoxygenase, LH2, 450002076$IPR002333:Hepatic lipase, 450012422$IPR013818:Lipase, N-terminal, 450014596$IPR016272:Lipoprotein lipase, LIPH]
lipase, hepatic,KEGG_PATHWAY[470038775$hsa00561:Glycerolipid metabolism]
lipase, hepatic,OMIM_DISEASE[520001129$Common variants at 30 loci contribute to polygenic dyslipidemia, 520001498$Diabetes mellitus, noninsulin-dependent, 520001986$Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis, 520001989$Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum, 520001995$Genome-wide association analysis of metabolic traits in a birth cohort from a founder population, 520002284$Hepatic lipase deficiency, 520002327$High density lipoprotein cholesterol level QTL 12, 520002930$Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts, 520003638$Newly identified loci that influence lipid concentrations and risk of coronary artery disease, 520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
lipase, hepatic,PIR_SUPERFAMILY[630001000$PIRSF000865:lipoprotein lipase, LIPH type, 630001001$PIRSF000865:Lipoprotein_lipase_LIPH]
lipase, hepatic,SMART[760000278$SM00308:LH2]
lipase, hepatic,SP_PIR_KEYWORDS[790000241$carboxylic ester hydrolase, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000616$glycoprotein, 790000643$hdl, 790000669$heparin-binding, 790000743$hydrolase, 790000869$lipid degradation, 790000870$lipid digestion, 790000873$lipid metabolism, 790000885$liver, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
lipase, hepatic,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850000090$active site:Nucleophile, 850023482$chain:Hepatic triacylglycerol lipase, 850105029$domain:PLAT, 850105770$glycosylation site:N-linked (GlcNAc...), 850111863$region of interest:Heparin-binding, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
lipoma HMGIC fusion partner-like 3,INTERPRO[450017610$IPR019372:Lipoma HMGIC fusion partner-like protein]
lipoma HMGIC fusion partner-like 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
lipoma HMGIC fusion partner-like 3,UP_SEQ_FEATURE[850028784$chain:Lipoma HMGIC fusion partner-like 3 protein, 850118623$transmembrane region]
olfactory receptor, family 4, subfamily F, member 17,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 4, subfamily F, member 17,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 4, subfamily F, member 17,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 4, subfamily F, member 17,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000919$membrane, 790001069$olfaction, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 4, subfamily F, member 17,UP_SEQ_FEATURE[850035768$chain:Olfactory receptor 4F17, 850102883$disulfide bond, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
peroxisomal biogenesis factor 6,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
peroxisomal biogenesis factor 6,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site]
peroxisomal biogenesis factor 6,OMIM_DISEASE[520003962$Peroxisomal biogenesis disorder, complementation group 4, 520003963$Peroxisomal biogenesis disorder, complementation group 6]
peroxisomal biogenesis factor 6,SMART[760000335$SM00382:AAA]
peroxisomal biogenesis factor 6,SP_PIR_KEYWORDS[790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000919$membrane, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001128$peroxisome, 790001129$peroxisome biogenesis, 790001130$peroxisome biogenesis disorder, 790001212$polymorphism, 790001304$repeat, 790001647$zellweger syndrome]
peroxisomal biogenesis factor 6,UP_SEQ_FEATURE[850037992$chain:Peroxisome assembly factor 2, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
plasmalemma vesicle associated protein,INTERPRO[450008637$IPR009538:PV-1]
plasmalemma vesicle associated protein,SP_PIR_KEYWORDS[790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000616$glycoprotein, 790000919$membrane, 790001409$Signal-anchor, 790001555$transmembrane]
plasmalemma vesicle associated protein,UP_SEQ_FEATURE[850039453$chain:Plasmalemma vesicle-associated protein, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
proteasome (prosome, macropain) 26S subunit, ATPase, 2,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
proteasome (prosome, macropain) 26S subunit, ATPase, 2,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site, 450005381$IPR005937:26S proteasome subunit P45]
proteasome (prosome, macropain) 26S subunit, ATPase, 2,KEGG_PATHWAY[470038819$hsa03050:Proteasome]
proteasome (prosome, macropain) 26S subunit, ATPase, 2,SMART[760000335$SM00382:AAA]
proteasome (prosome, macropain) 26S subunit, ATPase, 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790001063$nucleotide-binding, 790001065$nucleus, 790001254$proteasome]
proteasome (prosome, macropain) 26S subunit, ATPase, 2,UP_SEQ_FEATURE[850001245$chain:26S protease regulatory subunit 7, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict]
scaffold attachment factor B,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450002665$IPR003034:DNA-binding SAP, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
scaffold attachment factor B,PIR_SUPERFAMILY[630005055$PIRSF005098:human scaffold attachment factor B]
scaffold attachment factor B,SMART[760000328$SM00360:RRM, 760000456$SM00513:SAP]
scaffold attachment factor B,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001339$rna-binding, 790001539$Transcription, 790001543$transcription regulation]
scaffold attachment factor B,UP_SEQ_FEATURE[850058930$chain:Scaffold attachment factor B1, 850102404$compositionally biased region:Arg-rich, 850102507$compositionally biased region:Glu-rich, 850102517$compositionally biased region:Gly-rich, 850105211$domain:RRM, 850105257$domain:SAP, 850106258$modified residue, 850112689$region of interest:Interaction with POLR2A, 850112804$region of interest:Interaction with SAFB2, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal]
small EDRK-rich factor 1A (telomeric); small EDRK-rich factor 1B (centromeric),INTERPRO[450006867$IPR007513:Four F5 protein]
small EDRK-rich factor 1A (telomeric); small EDRK-rich factor 1B (centromeric),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
small EDRK-rich factor 1A (telomeric); small EDRK-rich factor 1B (centromeric),UP_SEQ_FEATURE[850060991$chain:Small EDRK-rich factor 1, 850118574$splice variant]
small nuclear ribonucleoprotein D2 polypeptide 16.5kDa; similar to hCG2040270,BIOCARTA[30000273$h_smPathway:Spliceosomal Assembly]
small nuclear ribonucleoprotein D2 polypeptide 16.5kDa; similar to hCG2040270,INTERPRO[450001020$IPR001163:Like-Sm ribonucleoprotein, core, 450006064$IPR006649:Like-Sm ribonucleoprotein, eukaryotic and archaea-type, core]
small nuclear ribonucleoprotein D2 polypeptide 16.5kDa; similar to hCG2040270,KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
small nuclear ribonucleoprotein D2 polypeptide 16.5kDa; similar to hCG2040270,PIR_SUPERFAMILY[630012536$PIRSF015770:small nuclear ribonucleoprotein Sm D2]
small nuclear ribonucleoprotein D2 polypeptide 16.5kDa; similar to hCG2040270,SMART[760000566$SM00651:Sm]
small nuclear ribonucleoprotein D2 polypeptide 16.5kDa; similar to hCG2040270,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001325$ribonucleoprotein, 790001433$Spliceosome, 790001478$systemic lupus erythematosus]
small nuclear ribonucleoprotein D2 polypeptide 16.5kDa; similar to hCG2040270,UP_SEQ_FEATURE[850061027$chain:Small nuclear ribonucleoprotein Sm D2, 850105852$helix, 850106258$modified residue, 850118575$strand]
speedy homolog E6 (Xenopus laevis); similar to speedy homolog A; speedy homolog E5 (Xenopus laevis); WBSCR19-like protein 8-like; speedy homolog E1 (Xenopus laevis),SP_PIR_KEYWORDS[790000356$complete proteome]
speedy homolog E6 (Xenopus laevis); similar to speedy homolog A; speedy homolog E5 (Xenopus laevis); WBSCR19-like protein 8-like; speedy homolog E1 (Xenopus laevis),UP_SEQ_FEATURE[850054603$chain:Putative Speedy protein E5, 850061777$chain:Speedy protein E1, 850102404$compositionally biased region:Arg-rich, 850117294$sequence conflict]
sterile alpha motif domain containing 12,INTERPRO[450001470$IPR001660:Sterile alpha motif SAM, 450010372$IPR011510:Sterile alpha motif homology 2, 450012380$IPR013761:Sterile alpha motif-type]
sterile alpha motif domain containing 12,SMART[760000399$SM00454:SAM]
sterile alpha motif domain containing 12,SP_PIR_KEYWORDS[790000356$complete proteome]
sterile alpha motif domain containing 12,UP_SEQ_FEATURE[850062450$chain:Sterile alpha motif domain-containing protein 12, 850105249$domain:SAM, 850117294$sequence conflict]
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1),INTERPRO[450000967$IPR001104:3-oxo-5-alpha-steroid 4-dehydrogenase, C-terminal, 450014957$IPR016636:3-oxo-5-alpha-steroid 4-dehydrogenase]
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1),KEGG_PATHWAY[470038739$hsa00140:Steroid hormone biosynthesis, 470038740$hsa00150:Androgen and estrogen metabolism]
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1),PIR_SUPERFAMILY[630012349$PIRSF015596:3-oxo-5-alpha-steroid 4-dehydrogenase 2, 630012350$PIRSF015596:5_alpha-SR2]
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1),SP_PIR_KEYWORDS[790000356$complete proteome, 790000434$differentiation, 790000499$endoplasmic reticulum, 790000919$membrane, 790000959$microsome, 790001092$oxidoreductase, 790001396$sexual differentiation, 790001555$transmembrane]
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1),UP_SEQ_FEATURE[850001504$chain:3-oxo-5-alpha-steroid 4-dehydrogenase 1, 850117294$sequence conflict, 850118623$transmembrane region]
two pore segment channel 1,INTERPRO[450005268$IPR005821:Ion transport]
two pore segment channel 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000344$coiled coil, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001304$repeat, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
two pore segment channel 1,UP_SEQ_FEATURE[850067305$chain:Two pore calcium channel protein 1, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ubiquitin-conjugating enzyme E2Z,INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
ubiquitin-conjugating enzyme E2Z,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
ubiquitin-conjugating enzyme E2Z,SMART[760000185$SM00212:UBCc]
ubiquitin-conjugating enzyme E2Z,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000859$ligase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001593$ubl conjugation pathway]
ubiquitin-conjugating enzyme E2Z,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850068114$chain:Ubiquitin-conjugating enzyme E2 Z, 850106258$modified residue, 850118574$splice variant]
uncoupling protein 3 (mitochondrial, proton carrier),INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001798$IPR002030:Mitochondrial brown fat uncoupling protein, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
uncoupling protein 3 (mitochondrial, proton carrier),OMIM_DISEASE[520003717$Obesity, severe, and type II diabetes]
uncoupling protein 3 (mitochondrial, proton carrier),PIR_SUPERFAMILY[630002575$PIRSF002458:ADP,ATP carrier protein]
uncoupling protein 3 (mitochondrial, proton carrier),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000430$diabetes mellitus, 790000446$disease mutation, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001067$obesity, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
uncoupling protein 3 (mitochondrial, proton carrier),UP_SEQ_FEATURE[850032051$chain:Mitochondrial uncoupling protein 3, 850114159$region of interest:Purine nucleotide binding, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
zinc finger CCCH-type containing 7B,INTERPRO[450000486$IPR000571:Zinc finger, CCCH-type, 450001282$IPR001440:Tetratricopeptide TPR-1, 450006475$IPR007087:Zinc finger, C2H2-type, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450014303$IPR015880:Zinc finger, C2H2-like, 450017972$IPR019734:Tetratricopeptide repeat]
zinc finger CCCH-type containing 7B,SMART[760000020$SM00028:TPR, 760000323$SM00355:ZnF_C2H2, 760000324$SM00356:ZnF_C3H1]
zinc finger CCCH-type containing 7B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000733$host-virus interaction, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat, 790001648$zinc, 790001651$zinc-finger]
zinc finger CCCH-type containing 7B,UP_SEQ_FEATURE[850101364$chain:Zinc finger CCCH domain-containing protein 7B, 850102565$compositionally biased region:Poly-Ala, 850106258$modified residue, 850106259$mutagenesis site, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117294$sequence conflict, 850117295$sequence variant, 850117548$short sequence motif:LD motif; interaction with NSP3, 850118574$splice variant, 850118655$zinc finger region:C2H2-type, 850118752$zinc finger region:C3H1-type 1, 850118753$zinc finger region:C3H1-type 2, 850118754$zinc finger region:C3H1-type 3, 850118756$zinc finger region:C3H1-type 4]
